• Mashup Score: 15
    Adrenal insufficiency - Nature Reviews Disease Primers - 2 year(s) ago

    Adrenal insufficiency (AI) is an endocrine disorder characterized by adrenal hypofunction, resulting in cortisol deficiency. In this Primer, Hahner and colleagues describe the different types of AI, their epidemiology, pathophysiology and diagnosis. Additionally, the authors discuss specific challenges associated with the long-term management of this disorder and strategies to prevent adrenal…

    Source: Nature
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of medpedshosp
      medpedshosp

      RT @DiseasePrimers: #AdrenalInsufficiency is the 9th most viewed Primer of this year. #BestOf2021 https://t.co/jRKS5JBMeM https://t.co/DZ…

  • Mashup Score: 2
    Consent Form - 3 year(s) ago

    Working… This value you provided is not a number. Please try again. This value you provided is not an integer. Please try again. The value entered is not a valid Vanderbilt Medical Record Number (i.e. 4- to 9-digit number, excluding leading zeros). Please try again. The value you provided must be within the suggested range. The value you provided is outside the suggested…

    Source: redcap.njhealth.org
    Categories: Latest Headlines, Rare Disease
    Tweet Tweets with this article
    • Profile photo of RareDiseases
      RareDiseases

      Attn adrenal insufficiency community! Very few studies in the US have addressed #AdrenalInsufficiency & even fewer have looked at quality of life or treatment options. @NADF_Adrenal encourages you to participate here to have your voices heard! https://t.co/cxZ1dDwoSy

  • Mashup Score: 0
    Gingival Pigmentation in a Boy - 3 year(s) ago

    A 6-year-old boy with influenza virus infection presented with hyponatremia, hypoglycemia, and a disproportionate lack of vitality. On examination, his gingiva were hyperpigmented (Figure 1). Laboratory results confirmed adrenal insufficiency because of a low cortisol level (1.0 μg/dL; reference, 3.7-19.4 μg/dL) and a high adrenocorticotropic hormone level (4530 pg/mL; reference, 7.2-63.3 pg/mL)….

    Source: The Journal of Pediatrics
    Categories: Latest Headlines, Pediatrics
    Tweet Tweets with this article
    • Profile photo of JPediatr
      JPediatr

      Gingival pigmentation may be a sign of adrenal insufficiency. #adrenalinsufficiency #adrenoleukodystrophy https://t.co/ZQjXmwiUOc https://t.co/hO9P7etXBU

  • Mashup Score: 3
    Benralizumab eliminates oral corticosteroid use in certain patients with severe asthma - 3 year(s) ago

    Patients with oral corticosteroid-dependent asthma treated with benralizumab achieved OCS elimination or reduction in those in whom adrenal insufficiency was detected, regardless of baseline eosinophil count, in the PONENTE trial.The multicenter, open-label, single-arm phase 3b trial evaluated the safety and efficacy of daily OCS dose reduction following initiation of benralizumab (Fasenra,

    Source: www.healio.com
    Categories: Latest Headlines, Pulmonology
    Tweet Tweets with this article
    • Profile photo of HealioPulm
      HealioPulm

      #Benralizumab eliminated or reduced oral corticosteroid use in patients with severe #asthma or reduced use in those with #Adrenalinsufficiency , presented at the #AAAAI21 virtual annual meeting https://t.co/SXQq5X2oj4

  • Mashup Score: 2
    Benralizumab eliminates oral corticosteroid use in certain patients with severe asthma - 3 year(s) ago

    Patients with oral corticosteroid-dependent asthma treated with benralizumab achieved OCS elimination or reduction in those in whom adrenal insufficiency was detected, regardless of baseline eosinophil count, in the PONENTE trial.The multicenter, open-label, single-arm phase 3b trial evaluated the safety and efficacy of daily OCS dose reduction following initiation of benralizumab (Fasenra,

    Source: www.healio.com
    Categories: Latest Headlines, Pulmonology
    Tweet Tweets with this article
    • Profile photo of HealioPulm
      HealioPulm

      #Benralizumab eliminated or reduced oral corticosteroid use in patients with severe #asthma or reduced use in those with #Adrenalinsufficiency , presented at the #AAAAI21 virtual annual meeting https://t.co/SXQq5WKMUu

  • Mashup Score: 0
    Benralizumab eliminates oral corticosteroid use in certain patients with severe asthma - 3 year(s) ago

    Patients with oral corticosteroid-dependent asthma treated with benralizumab achieved OCS elimination or reduction in those in whom adrenal insufficiency was detected, regardless of baseline eosinophil count, in the PONENTE trial.The multicenter, open-label, single-arm phase 3b trial evaluated the safety and efficacy of daily OCS dose reduction following initiation of benralizumab (Fasenra,

    Source: www.healio.com
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of GoHealio
      GoHealio

      #Benralizumab eliminated or reduced oral corticosteroid use in patients with severe #asthma or reduced use in those with #Adrenalinsufficiency , presented at the #AAAAI21 virtual annual meeting https://t.co/wnIRHc2EG0

    • Profile photo of HealioPulm
      HealioPulm

      #Benralizumab eliminated or reduced oral corticosteroid use in patients with severe #asthma or reduced use in those with #Adrenalinsufficiency , presented at the #AAAAI21 virtual annual meeting https://t.co/3d5U5ZfwuJ

Load More